tradingkey.logo

STRATA Skin Sciences Inc

SSKN

1.930USD

-0.020-1.03%
Horarios del mercado ETCotizaciones retrasadas 15 min
8.05MCap. mercado
PérdidaP/E TTM

STRATA Skin Sciences Inc

1.930

-0.020-1.03%
Más Datos de STRATA Skin Sciences Inc Compañía
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Información de la empresa
Símbolo de cotizaciónSSKN
Nombre de la empresaStrata Skin Sciences Inc
Fecha de salida a bolsaOct 28, 2005
Director ejecutivoDr. Dolev Rafaeli
Número de empleados106
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 28
Dirección5 Walnut Grove Drive, Suite 140
CiudadHORSHAM
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal19044
Teléfono12156193200
Sitio Webhttps://www.strataskinsciences.com/
Símbolo de cotizaciónSSKN
Fecha de salida a bolsaOct 28, 2005
Director ejecutivoDr. Dolev Rafaeli
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
143.16K
+334.33%
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
143.16K
+334.33%
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States (Country)
4.40M
64.55%
China
834.00K
12.24%
Middle East
711.00K
10.44%
Foreign
479.00K
7.03%
Other foreign
391.00K
5.74%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 9 de may
Actualizado: vie., 9 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Accelmed Growth Partners Management Ltd
34.57%
22NW, LP
12.87%
Nantahala Capital Management, LLC
9.68%
Rafaeli (Dolev)
3.43%
Renaissance Technologies LLC
2.44%
Other
37.00%
Accionistas
Accionistas
Proporción
Accelmed Growth Partners Management Ltd
34.57%
22NW, LP
12.87%
Nantahala Capital Management, LLC
9.68%
Rafaeli (Dolev)
3.43%
Renaissance Technologies LLC
2.44%
Other
37.00%
Tipos de accionistas
Accionistas
Proporción
Private Equity
34.57%
Investment Advisor/Hedge Fund
13.56%
Hedge Fund
12.86%
Individual Investor
3.91%
Investment Advisor
3.10%
Other
32.01%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
42
2.84M
68.02%
+23.70K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
2023Q3
53
2.57M
73.29%
-212.86K
2023Q2
52
2.46M
70.54%
-108.10K
2023Q1
52
2.47M
70.89%
-108.51K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Accelmed Growth Partners Management Ltd
1.44M
34.57%
--
--
Mar 31, 2025
22NW, LP
537.00K
12.87%
--
--
Mar 31, 2025
Nantahala Capital Management, LLC
403.92K
9.68%
--
--
Mar 31, 2025
Rafaeli (Dolev)
143.16K
3.43%
+110.20K
+334.33%
Mar 31, 2025
Renaissance Technologies LLC
101.83K
2.44%
-1.50K
-1.45%
Mar 31, 2025
The Vanguard Group, Inc.
84.63K
2.03%
+316.00
+0.37%
Mar 31, 2025
Citadel Advisors LLC
28.84K
0.69%
-2.38K
-7.63%
Mar 31, 2025
Rubinstein (Samuel)
19.86K
0.48%
+18.03K
+983.47%
Mar 31, 2025
Geode Capital Management, L.L.C.
18.27K
0.44%
+1.41K
+8.34%
Mar 31, 2025
MGO One Seven LLC
17.14K
0.41%
+17.14K
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proporción0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
Fecha
Tipo
Relación
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
Apr 26, 2024
Merger
10<1
KeyAI